These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6870483)

  • 1. Differential effects of diazepam and pentobarbital on mood and behavior.
    Griffiths RR; Bigelow GE; Liebson I
    Arch Gen Psychiatry; 1983 Aug; 40(8):865-73. PubMed ID: 6870483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug preference in humans: double-blind choice comparison of pentobarbital, diazepam and placebo.
    Griffiths RR; Bigelow GE; Liebson I; Kaliszak JE
    J Pharmacol Exp Ther; 1980 Dec; 215(3):649-61. PubMed ID: 7441524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-dose pharmacodynamics of diazepam and pentobarbital in substance abusers.
    Sullivan JT; Jasinski DR; Johnson RE
    Clin Pharmacol Ther; 1993 Dec; 54(6):645-53. PubMed ID: 8275619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative abuse liability of diazepam and oxazepam: behavioral and subjective dose effects.
    Griffiths RR; McLeod DR; Bigelow GE; Liebson IA; Roache JD
    Psychopharmacology (Berl); 1984; 84(2):147-54. PubMed ID: 6438672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethanol and pentobarbital: comparison of behavioral and subjective effects in sedative drug abusers.
    Mintzer MZ; Guarino J; Kirk T; Roache JD; Griffiths RR
    Exp Clin Psychopharmacol; 1997 Aug; 5(3):203-15. PubMed ID: 9260068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human sedative self-administration: effects of interingestion interval and dose.
    Griffiths RR; Bigelow GE; Liebson I
    J Pharmacol Exp Ther; 1976 Jun; 197(3):488-94. PubMed ID: 932989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug preference and mood in humans: diazepam.
    Johanson CE; Uhlenhuth EH
    Psychopharmacology (Berl); 1980; 71(3):269-73. PubMed ID: 6779334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rate of increase of plasma drug level influences subjective response in humans.
    de Wit H; Bodker B; Ambre J
    Psychopharmacology (Berl); 1992; 107(2-3):352-8. PubMed ID: 1615136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diazepam and triazolam self-administration in sedative abusers: concordance of subject ratings, performance and drug self-administration.
    Roache JD; Griffiths RR
    Psychopharmacology (Berl); 1989; 99(3):309-15. PubMed ID: 2594898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of response requirement upon human sedative self-administration and drug-seeking behavior.
    Bigelow GE; Griffiths RR; Liebson IA
    Pharmacol Biochem Behav; 1976 Dec; 5(6):681-5. PubMed ID: 1023234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the abuse potential of pagoclone, a partial GABAA agonist.
    de Wit H; Vicini L; Haig GM; Hunt T; Feltner D
    J Clin Psychopharmacol; 2006 Jun; 26(3):268-73. PubMed ID: 16702891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity to the effects of sedative-hypnotics on motor performance: influence of task difficulty and chronic phenobarbital administration.
    Smith MA; Stoops WW
    Behav Pharmacol; 2001 Apr; 12(2):125-34. PubMed ID: 11396517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flumazenil reverses the decrease in the hypnotic activity of pentobarbital by social isolation stress: are endogenous benzodiazepine receptor ligands involved?
    Ojima K; Matsumoto K; Watanabe H
    Brain Res; 1997 Jan; 745(1-2):127-33. PubMed ID: 9037401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the abuse liability of buspirone in recreational sedative users.
    Cole JO; Orzack MH; Beake B; Bird M; Bar-Tal Y
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):69-75. PubMed ID: 6130076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of triazolam and pentobarbital: performance impairment, subjective effects and abuse liability.
    Roache JD; Griffiths RR
    J Pharmacol Exp Ther; 1985 Jul; 234(1):120-33. PubMed ID: 2861282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiating effects of N1,N3-diallyluracil, N1,N3-diallylthymine and N1,N3-diallyl-6-methyluracil on pentobarbital-induced sleep and diazepam-induced motor incoordination.
    Tateoka Y; Kimura T; Watanabe K; Yamamoto I; Ho IK
    Chem Pharm Bull (Tokyo); 1987 Dec; 35(12):4928-34. PubMed ID: 3451813
    [No Abstract]   [Full Text] [Related]  

  • 17. Cross-dependence on ethanol and pentobarbital in rats reinforced on diazepam.
    Naruse T; Asami T
    Arch Int Pharmacodyn Ther; 1990; 304():147-62. PubMed ID: 2241408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subjective and behavioral effects of diazepam depend on its rate of onset.
    de Wit H; Dudish S; Ambre J
    Psychopharmacology (Berl); 1993; 112(2-3):324-30. PubMed ID: 7871037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response analysis of the behavioral effects of diazepam: II. Psychomotor performance, cognition and mood.
    Ghoneim MM; Mewaldt SP; Hinrichs JV
    Psychopharmacology (Berl); 1984; 82(4):296-300. PubMed ID: 6427817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic effects and abuse liability of bretazenil, diazepam, and alprazolam in humans.
    Busto U; Kaplan HL; Zawertailo L; Sellers EM
    Clin Pharmacol Ther; 1994 Apr; 55(4):451-63. PubMed ID: 8162672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.